Former subsidiary of the Roche Group operating the largest production site for sterile ampoules in Europe, Cenexi became an independent company in 2008. The company acquired two new production sites in Osny in France and in Braine l’Alleud in Belgium, respectively specialized in solid forms of hormonal and anti-allergy products and injectable oncologic products. Cenexi has also developed an offering of complementary services, including formulation, analytical development, product portfolio transfer management and regulatory support. These developments have allowed the company to enhance its client base, which today includes over 80 clients, and which mainly consists of international pharmaceutical groups, both generalist and specialist entities. Leveraging its solid industrial know-how and its operational excellence, all of Cenexi’s sites are registered with major world health authorities (FDA, Japan, China…), which allows the group to distribute its products in over 150 countries.